Profil
Walter Haeussler has served as a Director of Hemobiotech, Inc. since March 2004 and serves on the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee.
He is a Director of Thoriun Power, Inc. From August 1998 to August 2002, Mr. Haeussler served as the Director of Technology Transfer at Texas Tech University.
From August 2002 to March 2004, he served as General Counsel to Advisys, Inc. Previously, Mr. Haeussler served as the President of the Cornell Research Foundation at Cornell University from July 1993 to August 1998 and as Managing Partner of Jones Tallar & Cooper from 1972 to 1983.
He received a JD from Duquesne University.
Ehemalige bekannte Positionen von Walter Haeussler
| Unternehmen | Position | Ende |
|---|---|---|
Hemobiotech, Inc.
 Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Direktor/Vorstandsmitglied | 01.01.2008 |
Thorium Power, Inc.
 Thorium Power, Inc. Gas DistributorsUtilities Thorium Power, Inc. designs proliferation-resistant thorium-based nuclear fuels. The company is headquartered in McLean, VA. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |
Thorium Power, Inc.
Thorium Power, Inc. Gas DistributorsUtilities Thorium Power, Inc. designs proliferation-resistant thorium-based nuclear fuels. The company is headquartered in McLean, VA. | Utilities |
